Essity’s net sales decreased 4.5% in the third quarter of 2025 compared with the corresponding period a year ago and amounted to SEK 34.6 billion ($3.7 billion). Excluding currency translation effects, net sales increased SEK 322 million ($34 million).

Organic sales growth was 0.9%, mainly driven by higher prices. Volumes and product mix contributed positively. All business areas reported positive organic growth. Volumes were higher in Health & Medical and Consumer Goods. However, volumes were lower in Professional Hygiene, mainly due to lower demand in the hotel and restaurant sector. The product mix was slightly positive for the group, partly due to the increased sales of premium products in Professional Hygiene.

Growth was somewhat negative in Europe due to lower sales in Consumer Goods related to Consumer Tissue and Baby Care. Growth was positive in North America, driven by higher sales in Consumer Goods and Health & Medical. In Latin America, growth was strong, with high growth in Consumer Goods and Professional Hygiene.

In the Health & Medical segment, net sales increased organically 1.7% to SEK 6.9 billion ($732.6 million) as a result of higher volumes. Growth was favorable in both Europe and North America. In Incontinence Products Health Care, volumes were higher despite continued challenging market conditions. Sales prices and the product mix developed negatively. Organic growth in Medical Solutions was mainly driven by higher volumes. Sales prices were also higher and product mix was stable. Growth was favorable in all therapeutic areas and was especially high in compression therapy and wound care.

In the Consumer Goods segment, net sales increased organically 0.8% to SEK 18.6 billion ($1.97 billion), driven by higher volumes and sales prices. The product mix was slightly negative on account of growth in retailer brands in Consumer Tissue. The product mix was positive for other categories. Growth was negative in Europe. Growth was strong in both North and Latin America. Incontinence Products Retail and Feminine Care reported strong organic growth driven by higher volumes and prices. The Baby Care market in Europe remained challenging during the quarter, and growth in Baby Care was negative. In contrast, its leading Baby Care brand Libero noted strong growth in the Nordic region. Growth in Consumer Tissue was negative due to lower volumes in Europe.

In the Professional Hygiene segment, net sales increased organically 0.7% to SEK 9.2 billion ($976.8 million). The product mix remained favorable, featuring an increased share of premium products and higher sales prices. Volumes declined, negatively affected by reduced demand in the hotel and restaurant sector. Growth was high in Latin America and stable in Europe. In North America, growth was negative.